Identifying HIV infection in diagnostic histopathology tissue samples - The role of HIV-1 p24 immunohistochemistry in identifying clinically unsuspected HIV infection: A 3-year analysis

Histopathology

Volumn 56, Issue 4, 2010, Pages 530-541

  Moonim, Mufaddal T ^a   Alarcon, Lida ^a   Freeman, Janet ^a   Mahadeva, Ula ^a   Van Der Walt, Jon D ^a   Lucas, Sebastian B ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Acquired immunodeficiency syndrome; Diagnosis; Histopathology; HIV 1 p24; Human immunodeficiency virus; Immunohistochemistry

Indexed keywords

GAG PROTEIN;

ADOLESCENT; ADULT; ANUS; ARTICLE; BRAIN; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG; LYMPH NODE BIOPSY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NASOPHARYNX; PAROTID GLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SCHOOL CHILD; TONSIL; VIRUS LOAD;

ADOLESCENT; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; CYTODIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HIV CORE PROTEIN P24; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOID TISSUE; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; RETROSPECTIVE STUDIES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77949649989     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03513.x     Document Type: Article

References (34)

1. Weintrob AC, Giner J, Menezes P et al. Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Arch. Intern. Med. 2003 163 2097 2100.
2. Pantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993 362 355 358.
3. Grouard G, Clark EA. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis. Curr. Opin. Immunol. 1997 9 563 567.
4. Burton GF, Keele BF, Estes JD et al. Follicular dendritic cell contributions to HIV pathogenesis. Semin. Immunol. 2002 14 275 284.
5. di Marzo Veronese F, Sarngadharan MG, Rahman R et al. Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III. Proc. Natl Acad. Sci. USA 1985 82 5199 5202.
6. Kaluza G, Willems WR, Lohmeyer J, Altmannsberger M, Bohle RM, Lübke S. A monoclonal antibody that recognizes a formalin-resistant epitope on the p 24 core protein of HIV-1. Pathol. Res. Pract. 1992 188 91 96.
7. Baroni CD, Pezzella F, Mirolo M, Ruco LP, Rossi GB. Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS). Histopathology 1986 10 5 13.
8. Tenner-Racz K, Racz P, Bofill M et al. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and HIVD. Am. J. Pathol. 1986 123 9 15.
9. Spiegel H, Herbst H, Niedobitek G et al. Follicular dendritic cells are a major reservoir for Human Immunodeficiency virus type 1 in lymphoid tissue facilitating infection of CD4+ T-helper cells. Am. J. Pathol. 1992 140 15 22.
10. Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in HIVD-related lymphadenopathy. Lancet 1984 2 370 372.
11. Warner TF, Crass B, Gabel C, Maki D, Hafez GR, Golubjatnikov R. Diagnosis of HTLV-III infection by ultrastructural examination of germinal centres in lymph node - a case report. HIVD Res. 1986 2 43 50.
12. Tenner-Racz K, Stellbrink HJ, van Lunzen J et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J. Exp. Med. 1998 187 949 959.
13. Bruner JM, Cleary KR, Smith FB, Batsakis JG. Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions. J. Laryngol. Otol. 1989 103 1063 1066.
14. de Paiva GR, Laurent C, Godel A et al. Discovery of human immunodeficiency virus infection by immunohistochemistry on lymph node biopsies from patients with unexplained follicular hyperplasia. Am. J. Surg. Pathol. 2007 31 1534 1538.
15. Lucas SB, Curtis H, Johnson MA. National review of deaths among HIV-infected adults. Clin. Med. 2008 8 250 252.
16. Tenner-Rácz K, Rácz P, Dietrich M et al. Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS. AIDS 1987 1 95 104.
17. Kuster H, Opravil M, Ott P et al. Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection. Am. J. Pathol. 2000 156 1973 1986.
18. Wenig BM, Thompson LD, Frankel SS et al. Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases. Am. J. Surg. Pathol. 1996 20 572 587.
19. Orenstein JM, Wahl SM. The macrophage origin of the HIV-expressing multinucleated giant cells in hyperplastic tonsils and adenoids. Ultrastruct. Pathol. 1999 23 79 91.
20. Geijtenbeck TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell specific HIV-1 binding protein that enhances transfection of T cells. Cell 2000 100 587 597.
21. Simonitsch I, Geusau A, Chott A et al. Cutaneous dendritic cells are main targets in acute HIV-1 infection. Mod. Pathol. 2000 13 1232 1237.
22. Bobardt MD, Saphire AC, Hung HC et al. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 2003 18 27 39.
23. Kitchen SG, Korin YD, Roth MD et al. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J. Virol. 1998 72 9054 9060.
24. Motsinger A, Haas DW, Stanic AK et al. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 2002 195 869 879.
25. Price RW, Brew B, Sidtis J et al. The brain in HIVD: central nervous system HIV-1 infection and HIVD dementia complex. Science 1988 239 586 592.
26. Stebbing J, Gazzard B, Douek DC. Where does HIV live? N. Engl. J. Med. 2004 350 1872 1880.
27. Cavert W, Notermans DW, Staskus K et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997 276 960 964.
28. Perelson AS, Essunger P, Cao Y et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997 387 188 191.
29. Orenstein JM, Feinberg M, Yoder C et al. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS 1999 13 2219 2229.
30. Popovic M, Tenner-Racz K, Pelser C et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 2005 102 14807 14812.
31. Alòs L, Navarrete P, Morente V et al. Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence. Mod. Pathol. 2005 18 127 136.
32. Orenstein JM, Bhat N, Yoder C et al. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression. AIDS 2000 14 1709 1715.
33. Wong JK, Günthard HF, Havlir DV et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl Acad. Sci. USA 1997 94 12574 12579.
34. UK National guidelines for HIV testing 2008. http://bhiva.org/cms1222621. asp